Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -94.78%-486.12K | -286.30%-168.41K | 20.74%-95.44K | -200.61%-181.56K | -61.77%-40.71K | -12.85%-249.57K | 30.19%-43.6K | -442.70%-120.42K | 33.09%-60.4K | 45.59%-25.16K |
| Net income from continuing operations | -127.40%-553.92K | -217.06%-204.55K | -42.46%-109.59K | -174.60%-173.42K | -70.18%-66.36K | 58.26%-243.59K | 77.98%-64.52K | 47.26%-76.92K | 28.99%-63.16K | 29.97%-38.99K |
| Remuneration paid in stock | 39.91%21.34K | --0 | --0 | --0 | --21.34K | -72.44%15.25K | 153.64%15.25K | --0 | --0 | --0 |
| Change In working capital | 318.82%46.47K | 537.43%36.14K | 132.52%14.15K | -395.28%-8.14K | -68.77%4.32K | -402.13%-21.23K | 113.83%5.67K | -208.99%-43.49K | 308.23%2.76K | 46.61%13.83K |
| -Change in receivables | -80.09%1.38K | -243.78%-5.08K | 630.32%17.09K | -202.02%-8.67K | -113.58%-1.97K | 145.12%6.91K | 81.91%-1.48K | -218.38%-3.22K | 4.11%-2.87K | 562.58%14.47K |
| -Change in prepaid assets | 93.81%-836 | -0.33%7.17K | 89.73%-2.13K | ---7.31K | --1.43K | -280.07%-13.51K | -78.44%7.19K | ---20.7K | --0 | --0 |
| -Change in payables and accrued expense | 413.83%45.93K | 74,128.26%34.05K | 95.83%-816 | 39.30%7.84K | 854.59%4.85K | -198.66%-14.63K | 99.93%-46 | -147.83%-19.57K | 237.29%5.63K | -101.67%-643 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -94.78%-486.12K | -286.30%-168.41K | 20.74%-95.44K | -200.61%-181.56K | -61.77%-40.71K | -12.85%-249.57K | 30.19%-43.6K | -442.70%-120.42K | 33.09%-60.4K | 45.59%-25.16K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.03M | 51.45K | 243.94K | 733.48K | 4K | 0 | 0 | 0 | 0 | 0 |
| Net common stock issuance | --849.6K | --43K | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --288.64K | --39.2K | --243.94K | --1.5K | --4K | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---105.38K | ---30.75K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.03M | --51.45K | --243.94K | --733.48K | --4K | --0 | --0 | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -41.80%347.5K | 158.56%1.01M | 68.66%862.71K | -45.66%310.8K | -41.80%347.5K | 125.24%597.08K | 267.62%391.1K | 297.83%511.51K | 161.33%571.91K | 125.24%597.08K |
| Current changes in cash | 319.08%546.75K | -168.28%-116.96K | 223.33%148.5K | 1,013.79%551.91K | -45.87%-36.71K | -175.18%-249.57K | -108.88%-43.6K | -442.70%-120.42K | 33.09%-60.4K | 45.59%-25.16K |
| End cash Position | 157.34%894.26K | 157.34%894.26K | 158.56%1.01M | 68.66%862.71K | -45.66%310.8K | -41.80%347.5K | -41.80%347.5K | 267.62%391.1K | 297.83%511.51K | 161.33%571.91K |
| Free cash from | -94.78%-486.12K | -286.30%-168.41K | 20.74%-95.44K | -200.61%-181.56K | -61.77%-40.71K | -12.85%-249.57K | 30.19%-43.6K | -442.70%-120.42K | 33.09%-60.4K | 45.59%-25.16K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.